Ura N - Search Results

1

Mobile intracardiac calcinosis: a new risk of thromboembolism in patients with haemodialysed end stage renal disease.

Tsuchihashi K, Nozawa A, Marusaki S, Moniwa N, Oh-numa Y, Kuno A, Takagi S, Takizawa H, Ura N, Shimamoto K. Tsuchihashi K, et al. Among authors: ura n. Heart. 1999 Nov;82(5):638-40. doi: 10.1136/hrt.82.5.638. Heart. 1999. PMID: 10525525 Free PMC article.

2

Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease.

Tsuchihashi K, Takizawa H, Torii T, Ikeda R, Nakahara N, Yuda S, Kobayashi N, Nakata T, Ura N, Shimamoto K. Tsuchihashi K, et al. Among authors: ura n. Nephron. 2000 Jan;84(1):13-20. doi: 10.1159/000045533. Nephron. 2000. PMID: 10644903

3

Detection of cardiac calcinosis in hemodialysis patients by whole-body scintigraphy with 99m-technetium methylene diphosphonate.

Eguchi M, Tsuchihashi K, Takizawa H, Nakahara N, Hagiwara M, Ohnishi H, Torii T, Hashimoto A, Marusaki S, Nakata T, Ura N, Shimamoto K. Eguchi M, et al. Among authors: ura n. Am J Nephrol. 2000 Jul-Aug;20(4):278-82. doi: 10.1159/000013601. Am J Nephrol. 2000. PMID: 10970980

4

Serum ratio of heart-type fatty acid-binding protein to myoglobin. A novel marker of cardiac damage and volume overload in hemodialysis patients.

Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Nakata T, Shimamoto K. Furuhashi M, et al. Among authors: ura n. Nephron Clin Pract. 2003;93(2):C69-74. doi: 10.1159/000068520. Nephron Clin Pract. 2003. PMID: 12616033 Clinical Trial.

5

A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment.

Matsuda K, Shimamoto K, Ura N, Ogata H, Shizukuda Y, Iwakura M, Nozawa A, Kikuchi K, Iimura O. Matsuda K, et al. Among authors: ura n. Endocrinol Jpn. 1989 Oct;36(5):681-6. doi: 10.1507/endocrj1954.36.681. Endocrinol Jpn. 1989. PMID: 2620664 Free article.

6

Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease.

Nagao K, Tsuchihashi K, Ura N, Nakata T, Shimamoto K. Nagao K, et al. Among authors: ura n. Can J Cardiol. 1997 Aug;13(8):747-53. Can J Cardiol. 1997. PMID: 9284841 Review.

7

Sonoclot coagulation analysis: new bedside monitoring for determination of the appropriate heparin dose during haemodialysis.

Furuhashi M, Ura N, Hasegawa K, Yoshida H, Tsuchihashi K, Miura T, Shimamoto K. Furuhashi M, et al. Among authors: ura n. Nephrol Dial Transplant. 2002 Aug;17(8):1457-62. doi: 10.1093/ndt/17.8.1457. Nephrol Dial Transplant. 2002. PMID: 12147794

8

[Involvement of Insulin resistance in the pathogenesis of hypertensive target-organ damage].

Ura N, Shimamoto K. Ura N, et al. Nihon Rinsho. 2004 Mar;62 Suppl 3:207-10. Nihon Rinsho. 2004. PMID: 15171370 Review. Japanese. No abstract available.

9

Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction.

Furuhashi M, Ura N, Hasegawa K, Tsuchihashi K, Nakata T, Shimamoto K. Furuhashi M, et al. Among authors: ura n. Circ J. 2004 Jul;68(7):656-9. doi: 10.1253/circj.68.656. Circ J. 2004. PMID: 15226631 Free article.

10

Mechanisms of insulin resistance in hypertensive rats.

Shimamoto K, Ura N. Shimamoto K, et al. Among authors: ura n. Clin Exp Hypertens. 2006 Aug;28(6):543-52. doi: 10.1080/10641960600851900. Clin Exp Hypertens. 2006. PMID: 16893759 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters